OverviewSuggest Edit

Lantheus develops, manufactures and commercializes essential diagnostic imaging agents and products that help healthcare professionals identify disease and improve patient treatment and care. Its pioneering products assist physicians in the diagnosis of conditions affecting the heart, brain, lungs and other organs using echocardiography, nuclear imaging and magnetic resonance imaging (MRI) technologies.
The Company's products are routinely used to diagnose coronary artery disease (CAD), congestive heart failure (CHF), stroke, peripheral vascular (PVD) and other diseases. In addition to Lantheus's diversified portfolio of commercialized imaging agents and products, it has a strong development pipeline of internally-discovered next generation, first-in-class imaging agents that use positron emission tomography (PET), MRI technologies focused on enhancing current imaging modalities and fulfilling unmet diagnostic medical imaging needs.

TypePublic
Founded1956
HQBillerica, US
Websitelantheus.com
Employee Ratings2.8

Latest Updates

Employees (est.) (Feb 2019)483
Job Openings53
Revenue (FY, 2016)$301.9 M(+3%)
Share Price (Mar 2019)$24.7 (+3%)

Key People/Management at Lantheus Medical Imaging

Mary Anne Heino

Mary Anne Heino

President and Chief Executive Officer
Robert Marshall

Robert Marshall

Chief Financial Officer and Treasurer
John Bolla

John Bolla

Senior Vice President, Technical Operations
Sarah le Roy

Sarah le Roy

Senior Vice President, Human Resources
Etienne Montagut

Etienne Montagut

Senior Vice President, Corporate Development
Simon Robinson

Simon Robinson

Senior Vice President, Research and Pharmaceutical Development
Show more

Lantheus Medical Imaging Office Locations

Lantheus Medical Imaging has offices in Billerica, San Juan and Montréal
Billerica, US (HQ)
331 Treble Cove Rd, North Billerica
Montréal, CA
1111 Boulevard Dr.-Frederik-Philips, Suite 600
San Juan, PR
150 Calle Federico Acosta, Suite 1
Show all (3)
Report incorrect company information

Lantheus Medical Imaging Financials and Metrics

Lantheus Medical Imaging Revenue

Embed Graph
View revenue for all periods
Lantheus Medical Imaging's revenue was reported to be $301.85 m in FY, 2016 which is a 2.9% increase from the previous period.
USD

Revenue (Q1, 2017)

81.4m

Gross profit (Q1, 2017)

39.8m

Gross profit margin (Q1, 2017), %

48.9%

Net income (Q1, 2017)

4.1m

EBIT (Q1, 2017)

11.9m

Market capitalization (18-Mar-2019)

953.3m

Closing stock price (18-Mar-2019)

24.7

Cash (31-Mar-2017)

40.9m
Lantheus Medical Imaging's current market capitalization is $953.3 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

283.7m301.6m293.5m301.9m

Revenue growth, %

6%(3%)3%

Cost of goods sold

206.3m176.1m157.9m164.1m

Gross profit

77.4m125.5m135.5m137.8m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Revenue

70.4m73.3m75.6m75.7m74.8m73.3m74.1m76.5m78.0m73.1m81.4m

Cost of goods sold

46.7m43.3m44.6m44.0m39.1m40.6m40.4m42.8m42.2m39.4m41.6m

Gross profit

23.7m30.1m31.1m31.6m35.8m32.7m33.7m33.7m35.8m33.7m39.8m

Gross profit Margin, %

34%41%41%42%48%45%45%44%46%46%49%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

16.7m17.8m28.6m51.2m

Accounts Receivable

38.9m41.5m13.7m36.8m

Inventories

18.3m15.6m17.2m17.6m

Current Assets

77.3m79.2m90.1m110.8m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

20.9m15.1m14.1m25.2m28.8m22.2m21.9m38.9m54.9m53.2m40.9m

Accounts Receivable

39.9m

Inventories

17.0m18.5m16.3m16.4m16.2m15.4m16.6m15.5m14.4m16.1m19.8m

Current Assets

79.4m82.2m78.1m87.4m88.6m79.0m83.4m100.0m113.0m110.5m106.7m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(61.7m)(1.2m)(14.7m)26.8m

Depreciation and Amortization

25.2m9.9m19.7m18.3m

Inventories

(4.7m)(882.0k)(3.6m)

Accounts Payable

(1.1m)(4.0m)5.7m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(49.4m)(1.3m)(2.9m)(1.5m)657.0k(24.4m)5.4m10.3m7.4m4.2m4.1m

Depreciation and Amortization

21.7m5.0m9.9m14.8m

Inventories

(1.9m)(884.0k)1.1m668.0k15.4m16.6m15.5m14.4m16.1m19.8m

Accounts Payable

556.0k298.0k(4.3m)(3.0m)14.2m10.7m13.0m12.8m13.6m17.6m
USDY, 2017

Revenue/Employee

175.0k

Financial Leverage

-2.5 x
Show all financial metrics
Report incorrect company information

Lantheus Medical Imaging Blogs

Lantheus Holdings, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results

Lantheus Holdings, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results Content Import Tue, 02/19/2019 - 16:05 Lantheus Holdings, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results 02/19/19 This release is a backfill from a News Wire …

Lantheus Holdings Announces Earnings Release and Conference Call Dates for the Fourth Quarter and Full Year 2018

Lantheus Holdings Announces Earnings Release and Conference Call Dates for the Fourth Quarter and Full Year 2018 Content Import Tue, 02/05/2019 - 16:07 Lantheus Holdings Announces Earnings Release and Conference Call Dates for the Fourth Quarter and Full Year 2018 02/05/19 …

Lantheus Holdings to Present at the BMO Prescriptions for Success Healthcare Conference

NORTH BILLERICA, Mass. --(BUSINESS WIRE)--Nov. 28, 2018-- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products,

Credit Suisse Securities Healthcare Conference

Credit Suisse Securities Healthcare Conference Justin.Howard@… Mon, 11/05/2018 - 11:04 Credit Suisse Securities Healthcare Conference Display "add to calendar" true Event Type Corporate Conference Call Click here for webcast …

Lantheus Holdings to Present at Upcoming Investor Conferences

Lantheus Holdings to Present at Upcoming Investor Conferences Content Import Thu, 11/01/2018 - 16:10 Lantheus Holdings to Present at Upcoming Investor Conferences 11/01/18 This release is a backfill from a News Wire General NORTH BILLERICA,…

Lantheus Holdings, Inc. Reports Third Quarter 2018 Financial Results

Lantheus Holdings, Inc. Reports Third Quarter 2018 Financial Results Content Import Tue, 10/30/2018 - 16:05 Lantheus Holdings, Inc. Reports Third Quarter 2018 Financial Results 10/30/18 This release is a backfill from a News Wire Earnings …
Show more

Lantheus Medical Imaging Frequently Asked Questions

  • When was Lantheus Medical Imaging founded?

    Lantheus Medical Imaging was founded in 1956.

  • Who are Lantheus Medical Imaging key executives?

    Lantheus Medical Imaging's key executives are Mary Anne Heino, Robert Marshall and John Bolla.

  • How many employees does Lantheus Medical Imaging have?

    Lantheus Medical Imaging has 483 employees.

  • What is Lantheus Medical Imaging revenue?

    Latest Lantheus Medical Imaging annual revenue is $301.9 m.

  • What is Lantheus Medical Imaging revenue per employee?

    Latest Lantheus Medical Imaging revenue per employee is $625 k.

  • Who are Lantheus Medical Imaging competitors?

    Competitors of Lantheus Medical Imaging include Analogic, IZI Medical Products and Eckert & Ziegler.

  • Where is Lantheus Medical Imaging headquarters?

    Lantheus Medical Imaging headquarters is located at 331 Treble Cove Rd, North Billerica, Billerica.

  • Where are Lantheus Medical Imaging offices?

    Lantheus Medical Imaging has offices in Billerica, San Juan and Montréal.

  • How many offices does Lantheus Medical Imaging have?

    Lantheus Medical Imaging has 3 offices.